Co-Expression of Programmed Death-Ligand 1 (PD-L1) Expression in EGFR Mutant Stage IV Lung Adenocarcinoma

被引：0
|
作者：
Hsu, P. [1 ]
Wang, C. [2 ]
Kuo, S. [3 ]
Yang, C. [4 ]
机构：
[1] Chang Gung Med Fdn, Taoyuan, Taoyuan County, Taiwan
[2] Chang Gung Med Fdn, Dept Pathol, Taoyuan, Taoyuan County, Taiwan
[3] Chang Gung Med Fdn, Dept Thorac Med, Taoyuan, Taoyuan County, Taiwan
[4] Chang Gung Mem Hosp, Taoyuan, Taiwan
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2019年 / 199卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A7292
引用
收藏
页数：1
相关论文
共 50 条
  • [1] The Co-Expression of Programmed Death-Ligand 1 (PD-L1) in Untreated EGFR-Mutated Metastatic Lung Adenocarcinoma
    Hsu, Ping-Chih
    Wang, Chih-Wei
    Kuo, Scott Chih-Hsi
    Lin, Shu-Min
    Lo, Yu-Lun
    Huang, Allen Chung-Cheng
    Chiu, Li-Chung
    Yang, Cheng-Ta
    BIOMEDICINES, 2020, 8 (02)
  • [2] Programmed death-ligand 1 (PD-L1) expression in pleomorphic carcinoma of the lung
    Imanishi, Naoko
    Hirai, Ayako
    Yoneda, Kazue
    Shimajiri, Shohei
    Kuwata, Taiji
    Tashima, Yuko
    Takeuchi, Masahiro
    Iwai, Yoshiko
    Ichiki, Yoshinobu
    Tanaka, Fumihiro
    JOURNAL OF SURGICAL ONCOLOGY, 2018, 117 (07) : 1563 - 1569
  • [3] PROGRAMMED DEATH-LIGAND 1 (PD-L1) EXPRESSION IN PHEOCHROMOCYTOMA
    Hashimoto, Yasuhiro
    Imai, Atsushi
    Hatakeyama, Shingo
    Yoneyama, Takahiro
    Koie, Takuya
    Ohyama, Chikara
    JOURNAL OF UROLOGY, 2017, 197 (04): : E474 - E474
  • [4] Programmed death-ligand 1 (PD-L1) expression in pheochromocytoma.
    Hashimoto, Yasuhiro
    Yamamoto, Hayato
    Hatakeyama, Shingo
    Yoneyama, Takahiro
    Ohyama, Chikara
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (07)
  • [5] Programmed death-ligand 1 (PD-L1) expression in primary gastric adenocarcinoma and matched metastases
    Liu, Drolaiz H. W.
    Grabsch, Heike I. I.
    Gloor, Beat
    Langer, Rupert
    Dislich, Bastian
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (14) : 13345 - 13352
  • [6] Programmed death-ligand 1 (PD-L1) expression in primary gastric adenocarcinoma and matched metastases
    Drolaiz H. W. Liu
    Heike I. Grabsch
    Beat Gloor
    Rupert Langer
    Bastian Dislich
    Journal of Cancer Research and Clinical Oncology, 2023, 149 : 13345 - 13352
  • [7] Programmed Death-Ligand 1 (PD-L1) Expression in Pheochromocytoma: Clinicopathologic Correlation
    Xiong, Meng-Jun
    Kissick, Haydn
    Master, Viraj
    Osunkoya, Adeboye O.
    LABORATORY INVESTIGATION, 2019, 99
  • [8] Programmed Death-ligand 1 (PD-L1) Expression in Thymic Epithelial Tumors
    Bedekovics, Judit
    Beke, Livia
    Mokanszki, Attila
    Szilagyi, Szabolcs
    Mehes, Gabor
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2020, 28 (01) : 1 - 9
  • [9] Programmed Death-Ligand 1 (PD-L1) Expression in Pheochromocytoma: Clinicopathologic Correlation
    Xiong, Meng-Jun
    Kissick, Haydn
    Master, Viraj
    Osunkoya, Adeboye O.
    MODERN PATHOLOGY, 2019, 32
  • [10] Programmed Cell Death-Ligand 1 (PD-L1) Expression in Anal Cancer
    Govindarajan, Rangaswamy
    Gujja, Swetha
    Siegel, Eric R.
    Batra, Anu
    Saeed, Anwaar
    Lai, Keith
    James, Jennifer D.
    Fogel, Bradley J.
    Williamson, Stephen
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2018, 41 (07): : 638 - 642
12345